APA (7th ed.) Citation

Juanjuan Jiang, Li Xu, Lin Chai, Xiaoyuan Guan, Li Zhang, Hong Liu, . . . Youhong Jia. (2024). Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long‐acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double‐blind, placebo‐controlled phase Ia and Ib/II studies. Wiley.

Chicago Style (17th ed.) Citation

Juanjuan Jiang, et al. Clinical Pharmacokinetics and Pharmacodynamics of Ongericimab: A Potential Long‐acting PCSK9 Monoclonal Antibody in Healthy Subjects and Patients with Hypercholesterolemia: Randomized, Double‐blind, Placebo‐controlled Phase Ia and Ib/II Studies. Wiley, 2024.

MLA (9th ed.) Citation

Juanjuan Jiang, et al. Clinical Pharmacokinetics and Pharmacodynamics of Ongericimab: A Potential Long‐acting PCSK9 Monoclonal Antibody in Healthy Subjects and Patients with Hypercholesterolemia: Randomized, Double‐blind, Placebo‐controlled Phase Ia and Ib/II Studies. Wiley, 2024.